• Redefining Cell Viability: Mechanistic Insights for TNBC Fer

  2026-04-28

  This thought-leadership piece bridges the cutting-edge mechanistic findings from ferroptosis research in triple-negative breast cancer (TNBC) with practical, protocol-level guidance for translational scientists. We examine how robust live/dead discrimination using the Live-Dead Cell Staining Kit I (Calcein AM/PI) empowers the validation of novel cell death modalities, such as gramine-induced ferroptosis, and offer strategic recommendations for designing next-generation cytotoxicity assays.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Fluorescent Precisio

  2026-04-28

  Harness the sensitivity of the Cy5 Goat Anti-Mouse IgG (H+L) Antibody for amplified fluorescent detection in advanced immunoassays. Discover workflow enhancements, troubleshooting strategies, and how new vaccine research informs practical assay design.

• Poly-GA Drives Tau Pathology via ERK1/2: Insights from C9orf

  2026-04-27

  This study uncovers how poly-glycine-alanine (poly-GA) dipeptide repeats, derived from C9orf72 hexanucleotide expansions, promote tau hyperphosphorylation and neuronal cell death by directly activating ERK1/2 signaling in cellular models of FTLD. The findings highlight ERK1/2 as a mechanistic link and potential therapeutic target for tau pathology in C9orf72-associated neurodegeneration.

• CGP 55845 Hydrochloride: GABAB Receptor Antagonist in Synapt

  2026-04-27

  CGP 55845 hydrochloride empowers researchers to dissect GABAB receptor function with unrivaled selectivity, facilitating advanced in vitro neurotransmission assays and astrocyte-focused workflows. This article translates cutting-edge findings into actionable protocols and troubleshooting strategies for maximal experimental clarity.

• Red Blood Cell Lysis Buffer: Precision Erythrocyte Removal f

  2026-04-26

  Unlock reproducible blood sample preparation with Red Blood Cell Lysis Buffer—formulated for selective erythrocyte removal while preserving nucleated cells. Discover protocol enhancements, advanced troubleshooting, and translational insights that set this APExBIO solution apart for flow cytometry, nucleic acid, and protein workflows.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-04-25

  This study introduces a physiologically relevant gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations, better capturing the complexity of the tumor microenvironment. The platform enables nuanced investigation of drug resistance, biomarker expression, and personalized therapeutic response, enhancing preclinical research and translational strategies.

• ATRX-Deficient Gliomas: Enhanced Sensitivity to RTK/PDGFR In

  2026-04-24

  This study identifies that high-grade glioma cells lacking ATRX are markedly more sensitive to receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibition, including in combination with temozolomide. These findings support incorporating ATRX mutation status into the design and interpretation of targeted therapy trials for glioma.

• Carbapenemase Genes in CREC: Prevalence, Mobility, and Resis

  2026-04-24

  Chen et al. (2025) provide a detailed molecular epidemiology of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China. The study reveals a high prevalence of blaNDM-1 on plasmids, frequent multidrug resistance, and extensive horizontal gene transfer, with important implications for infection control and Gram-negative bacterial infection research.

• Ademetionine in Neurological Disorders: Methylation and Clin

  2026-04-23

  This review synthesizes the neurochemical and clinical importance of methylation in neurological disorders, highlighting ademetionine (S-adenosylmethionine, SAMe) as a crucial methyl donor. The findings clarify how SAMe metabolism interfaces with folate and vitamin B12, impacting neuropsychiatric symptoms and offering therapeutic potential in depression, dementia, and remyelinating disorders.

• Maraviroc (UK-427857): Applied Workflows for HIV and Neuroin

  2026-04-23

  Maraviroc (UK-427857) enables precise HIV-1 entry inhibition and provides translational impact in neuroinflammation and ischemic stroke research. This article delivers actionable workflows, troubleshooting strategies, and protocol parameters—anchored in both literature and APExBIO’s product expertise—to optimize your research outcomes.

• mTORC1-IRE1α Axis Drives Palmitate-Induced Lipotoxicity in L

  2026-04-22

  This study reveals that activation of the mTORC1-IRE1α signaling pathway is central to palmitate-induced triglyceride overproduction and hepatocyte cell death. The mechanistic insight identifies potential therapeutic targets for metabolic diseases associated with lipotoxicity, such as nonalcoholic fatty liver disease.

• MLN4924: Translating Neddylation Inhibition Into Cancer Brea

  2026-04-22

  This article explores MLN4924, a highly selective NEDD8-activating enzyme inhibitor, through a lens of mechanistic depth and translational relevance. It synthesizes recent advances in neddylation pathway inhibition, draws on new evidence from head and neck carcinoma models, and provides actionable guidance for researchers. The discussion contextualizes MLN4924 within both the competitive reagent landscape and the emerging paradigm of multi-targeted therapy, while highlighting APExBIO's role in enabling translational success.

• Indomethacin in Inflammation and Lipid Metabolism Research

  2026-04-21

  Indomethacin is more than a nonsteroidal anti-inflammatory drug—its unique dual action on Cox-1 and PPARγ empowers advanced workflows in inflammation and adipocyte differentiation studies. Discover how APExBIO’s Indomethacin supports robust, reproducible protocols and enables deeper mechanistic insights.

• Tetramethylrhodamine Ethyl Ester Perchlorate in Live Mitocho

  2026-04-21

  Tetramethylrhodamine ethyl ester perchlorate (TMRE) from APExBIO enables high-fidelity, quantitative assessment of mitochondrial membrane potential in live cells, streamlining workflows for mitochondrial dysfunction and oxidative stress research. This article translates recent mechanistic breakthroughs into actionable protocols, troubleshooting tactics, and advanced applications, empowering bench scientists to dissect mitochondrial health with precision.

• Microbiota–Tryptophan–AhR Axis in Ulcerative Colitis Repair

  2026-04-20

  Li et al. (2026) identify a mechanistic axis linking microbiota-driven tryptophan metabolism to AhR-mediated intestinal stem cell differentiation, elucidating how Huangqin decoction (HQD) repairs mucosal damage in ulcerative colitis. This work clarifies the central role of microbiota–metabolite–AhR–stem cell interactions in epithelial regeneration and highlights experimental approaches for dissecting these pathways.

14627 records 1/976 page Next 12345 下5页 Last page